restor3d has raised nearly $14 million in funding, and plans to add up to $8 million more. The funding comes from 147 investors, and all of the investment will come in the form of equity.
Last year, the firm raised $13 million from 101 investors and announced its merger with Kinos Medical, a total ankle replacement manufacturer. In 2019, restor3d entered into a licensing and development agreement with SeaSpine to produce 3D-printed interbody implants.
restor3d seeks to help surgeons repair and reconstruct the human body by uniting 3D printing, biomaterials, biomechanics and artificial intelligence. Technology developed by restor3d can be put in place within 14 days.
The company has ties to Duke University, including its co-founder, Ken Gall, Ph.D., who has stated that the future of surgical reconstructions would “be performed with implants that are tuned to the anatomy, biomechanics and tissue biology of individual patients and explicitly designed and improved based on data sets of pre- and post- operative clinical data.”
restor3d has raised nearly $14 million in funding, and plans to add up to $8 million more. The funding comes from 147 investors, and all of the investment will come in the form of equity.
Last year, the firm raised $13 million from 101 investors and announced its merger with Kinos Medical, a total ankle replacement manufacturer. In 2019,...
restor3d has raised nearly $14 million in funding, and plans to add up to $8 million more. The funding comes from 147 investors, and all of the investment will come in the form of equity.
Last year, the firm raised $13 million from 101 investors and announced its merger with Kinos Medical, a total ankle replacement manufacturer. In 2019, restor3d entered into a licensing and development agreement with SeaSpine to produce 3D-printed interbody implants.
restor3d seeks to help surgeons repair and reconstruct the human body by uniting 3D printing, biomaterials, biomechanics and artificial intelligence. Technology developed by restor3d can be put in place within 14 days.
The company has ties to Duke University, including its co-founder, Ken Gall, Ph.D., who has stated that the future of surgical reconstructions would “be performed with implants that are tuned to the anatomy, biomechanics and tissue biology of individual patients and explicitly designed and improved based on data sets of pre- and post- operative clinical data.”
Our site uses cookies to allow easier access for Members and subscribers and to improve our site. You agree to our use of cookies by closing this message box or continuing to use our site.OkRead more
Copy to clipboard 
